{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:11:27Z","timestamp":1787026287671,"version":"build-2736575974"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Lassa virus (LASV) causes an acute multisystemic hemorrhagic fever in humans known as Lassa fever, which is endemic in several African countries. This manuscript focuses on the progression of disease in cynomolgus macaques challenged with aerosolized LASV and serially sampled for the development and progression of gross and histopathologic lesions. Gross lesions were first noted in tissues on day 6 and persisted throughout day 12. Viremia and histologic lesions were first noted on day 6 commencing with the pulmonary system and hemolymphatic system and progressing at later time points to include all systems. Immunoreactivity to LASV antigen was first observed in the lungs of one macaque on day 3 and appeared localized to macrophages with an increase at later time points to include immunoreactivity in all organ systems. Additionally, this manuscript will serve as a detailed atlas of histopathologic lesions and disease progression for comparison to other animal models of aerosolized Arenaviral disease.<\/jats:p>","DOI":"10.3389\/fcimb.2024.1341891","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:01:18Z","timestamp":1707436878000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["An atlas of gross and histologic lesions and immunohistochemical immunoreactivity during the temporal progression of aerosolized Lassa virus induced hemorrhagic fever in cynomolgus macaques"],"prefix":"10.3389","volume":"14","author":[{"given":"Forrest","family":"Bohler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Cashman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Rosenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Shamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Honko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Shaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1177\/0300985816677153","article-title":"Temporal progression of lesions in Guinea pigs infected with lassa virus","volume":"54","author":"Bell","year":"2017","journal-title":"Veterinary Pathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"935","DOI":"10.4269\/ajtmh.16-0675","article-title":"At home with mastomys and rattus: human-rodent interactions and potential for primary transmission of lassa virus in domestic spaces","volume":"96","author":"Bonwitt","year":"2017","journal-title":"Am. J. Trop. Med. Hygiene"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/s40696-016-0018-3","article-title":"Lassa fever: another threat from West Africa","volume":"2","author":"Brosh-Nissimov","year":"2016","journal-title":"Disaster Military Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.chom.2022.10.018","article-title":"Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection","volume":"30","author":"Brouwer","year":"2022","journal-title":"Cell Host Microbe"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1126\/science.282.5396.2079","article-title":"Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and lassa fever virus","volume":"282","author":"Cao","year":"1998","journal-title":"Sci. (New York N.Y.)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01896-18","article-title":"Immune-mediated systemic vasculitis as the proposed cause of sudden-onset sensorineural hearing loss following lassa virus exposure in cynomolgus macaques","volume":"9","author":"Cashman","year":"2018","journal-title":"mBio"},{"key":"B7","unstructured":"Emergency Preparedness & Response2019"},{"key":"B8","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2307\/1382739","article-title":"Rodent-borne hemorrhagic fever viruses: A special risk for mammalogists","volume":"76","author":"Childs","year":"1995","journal-title":"J. Mammalogy"},{"key":"B9","doi-asserted-by":"publisher","first-page":"pp.10329","DOI":"10.1128\/JVI.01624-16","article-title":"Role of LAMP1 binding and pH sensing by the spike complex of Lassa virus","volume":"90","author":"Cohen-Dvashi","year":"2016","journal-title":"J. Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/bij.12013","article-title":"A mitochondrial phylogeographic scenario for the most widespread african rodent, mastomys natalensis","volume":"108","author":"Colangelo","year":"2013","journal-title":"Biol. J. Linn. Soc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.coviro.2019.07.003","article-title":"Antibody therapy for lassa fever","volume":"37","author":"Cross","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.antiviral.2016.08.012","article-title":"Treatment of lassa virus infection in outbred Guinea pigs with first-in-class human monoclonal antibodies","volume":"133","author":"Cross","year":"2016","journal-title":"Antiviral Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1001\/jama.1990.03450160063030","article-title":"Acute sensorineural deafness in Lassa fever","volume":"264","author":"Cummins","year":"1990","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/v12060593","article-title":"Natural history of aerosol induced lassa fever in non-human primates","volume":"12","author":"Downs","year":"2020","journal-title":"Viruses"},{"key":"B15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/0300-1652.132037","article-title":"Acute abdominal pain in patients with lassa fever: radiological assessment and diagnostic challenges","volume":"55","author":"Eze","year":"2014","journal-title":"Nigerian Med. Journal: J. Nigeria Med. Assoc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijid.2020.08.021","article-title":"Lassa fever-induced hearing loss: the neglected disability of hemorrhagic fever","volume":"100","author":"Ficenec","year":"2020","journal-title":"Int. J. Infect. Diseases: IJID: Off. Publ. Int. Soc. Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.4269\/ajtmh.1970.19.670","article-title":"Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings","volume":"19","author":"Frame","year":"1970","journal-title":"Am. J. Trop. Med. Hygiene"},{"key":"B18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41579-022-00789-8","article-title":"Lassa fever \u2014 the road ahead","volume":"21","author":"Garry","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1086\/322033","article-title":"Lassa fever encephalopathy: lassa virus in cerebrospinal fluid but not in serum","volume":"184","author":"G\u00fcnther","year":"2001","journal-title":"J. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.coviro.2019.08.002","article-title":"Lassa fever diagnostics: past, present, and future","volume":"37","author":"Happi","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"13793","DOI":"10.1128\/jvi.78.24.13793-13803.2004","article-title":"Replicon system for lassa virus","volume":"78","author":"Hass","year":"2004","journal-title":"J. Virol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1186\/1743-422X-8-205","article-title":"Pathogenesis of lassa fever in cynomolgus macaques","volume":"8","author":"Hensley","year":"2011","journal-title":"Virol. J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"10.1128\/aac.01146","DOI":"10.1128\/aac.01146-20","article-title":"Inhibition of arenaviruses by combinations of orally available approved drugs","volume":"65","author":"Herring","year":"2021","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B24","volume-title":"HHS and USDA Select Agents and Toxins: 7 CFR Part 331, 9 CFR Part 121, and 42 CFR Part 73","year":"2023"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fitd.2023.1107786","article-title":"Ophthalmic consequences of viral hemorrhagic fevers: insights from the clinic and laboratory.\u201d","volume":"4","author":"Karnam","year":"2023","journal-title":"Front. Trop. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/trstmh\/traa011","article-title":"Lassa fever in pregnancy: A systematic review and meta-analysis","volume":"114","author":"Kayem","year":"2020","journal-title":"Trans. R. Soc. Trop. Med. Hygiene"},{"key":"B27","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3201\/eid2502.180836","article-title":"Lassa fever in travelers from West Africa 1969\u20132016","volume":"25","author":"Kofman","year":"2019","journal-title":"Emerging Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3201\/eid2108.150312","article-title":"Lassa virus in multimammate rats, c\u00f4te d\u2019Ivoire 2013","volume":"21","author":"Kouadio","year":"2015","journal-title":"Emerging Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1128\/JVI.79.10.5979-5987.2005","article-title":"Characterization of the interaction of lassa fever virus with its cellular receptor \u03b1-dystroglycan","volume":"79","author":"Kunz","year":"2005","journal-title":"J. Virol."},{"key":"B30","unstructured":"2022"},{"key":"B31","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3201\/eid1205.050052","article-title":"Historical lassa fever reports and 30-year clinical update","volume":"12","author":"Macher","year":"2006","journal-title":"Emerging Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002171","article-title":"Transcriptional profiling of the circulating immune response to lassa virus in an aerosol model of exposure","volume":"7","author":"Malhotra","year":"2013","journal-title":"PloS Negl. Trop. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-3-642-56029-3_4","article-title":"Lassa fever","volume":"262","author":"McCormick","year":"2002","journal-title":"Curr. Topics Microbiol. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nm.4396","article-title":"\u201cHuman-monoclonal-antibody therapy protects nonhuman primates against advanced lassa fever.\u201d","volume":"23","author":"Mire","year":"2017","journal-title":"Nat. Med."},{"key":"B35","volume-title":"NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines)","year":"2019"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.onehlt.2021.100346","article-title":"The one health approach to incident management of the 2019 lassa fever outbreak response in Nigeria","volume":"13","author":"Nwafor","year":"2021","journal-title":"One Health"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.07.2107","article-title":"Central nervous system manifestations of lassa fever in nigeria and the effect on mortality","volume":"333","author":"Okokhere","year":"2013","journal-title":"J. Neurological Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/bmj.297.6648.584","article-title":"A prospective study of maternal and fetal outcome in acute lassa fever infection during pregnancy","volume":"297","author":"Price","year":"1988","journal-title":"BMJ"},{"key":"B39","unstructured":"Prioritizing Diseases for Research and Development in Emergency Contexts2023"},{"key":"B40","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/B978-0-12-814515-9.00014-X","article-title":"Human pathogenic arenaviruses (Arenaviridae)","volume":"100","author":"Radoshitzky","year":"2019","journal-title":"Encyclopedia Virol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","article-title":"Lassa fever: epidemiology, clinical features, and social consequences","volume":"327","author":"Richmond","year":"2003","journal-title":"BMJ: Br. Med. J."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010289","article-title":"Ribavirin for treating lassa fever: A systematic review of pre-clinical studies and implications for human dosing","volume":"16","author":"Salam","year":"2022","journal-title":"PloS Negl. Trop. Dis."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00232","article-title":"Lassa fever 2016 outbreak in plateau state, nigeria\u2014The changing epidemiology and clinical presentation","volume":"6","author":"Shehu","year":"2018","journal-title":"Front. Public Health"},{"key":"B44","doi-asserted-by":"publisher","first-page":"10700","DOI":"10.1128\/jvi.77.19.10700-10705.2003","article-title":"Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [Corrected]","volume":"77","author":"Strecker","year":"2003","journal-title":"J. Virol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0035-9203(72)90269-6","article-title":"Lassa fever: a study of 23 hospital cases","volume":"66","author":"White","year":"1972","journal-title":"Trans. R. Soc. Trop. Med. Hygiene"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1341891\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:01:23Z","timestamp":1707436883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1341891\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":45,"alternative-id":["10.3389\/fcimb.2024.1341891"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1341891","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]},"article-number":"1341891"}}